New-onset refractory status epilepticus (NORSE) is a rare clinical presentation of refractory status epilepticus (RSE) that occurs in people without active epilepsy or preexisting neurologic disorder. New-onset refractory status epilepticus does not resolve after 2 or more rescue antiseizure medications, and it presents without a clear acute or active structural, toxic, or metabolic etiology. 1 Febrile infection-related epilepsy syndrome (FIRES) is a subcategory of NORSE and requires a febrile infection between 2 weeks and 24 hours before the start of RSE, with or without fever at the onset of RSE. 1 New-onset refractory status epilepticus/FIRES are becoming increasingly recognized; however, information pertaining to disease course, clinical outcomes, and survivorship remains limited, and mortality and morbidity are variable but often high. 2 The objective of the NORSE/FIRES Family Registry is to (1) provide an easily accessible and internationally available multilingual registry into which survivors or NORSE/FIRES surrogates or family members of people affected by NORSE/FIRES or their physicians can enter data in a systematic and rigorous research study from anywhere in the world where internet is available; and (2) to examine past medical history, outcomes, and quality of life for people affected by NORSE/FIRES.
The NORSE Family registry invites survivors, their loved ones or substitute decision-makers to enter data along with their health care professionals. It is managed using REDCap (Research Electronic Data Capture tool) hosted at Lawson Health Research Institute, affiliated with Western University (London, ON, Canada). All participants must provide electronic informed consent before accessing the online survey. Within the survey we will ask questions about past medical history, clinical presentation, disease course, survivorship, clinical sequelae, and quality of life, among others. If applicable, the survey invites participants to return at 6, 12, and 24 months after disease onset to gather ongoing information on survivorship, long-term outcomes, and quality of life. If participants are already beyond 24 months after disease onset, they are invited to provide data regarding the same variables at the time they are completing the survey. The survey has several features to make data input accessible and user friendly, such as save and return options, email notifications, and detailed instructions for participants. The registry will remain open until 2025. The survey can be accessed at http://www.norseinstitute.org/norse-registry-2.
The NORSE/FIRES Family Registry is a collaborative project developed by members of the NORSE Institute (www.norseinstitute.org). It will allow for the collection of a wide range of clinical and epidemiological variables which will provide a stepping stone for future systematic research. Most importantly, the NORSE/FIRES Family Registry provides an opportunity for families and survivors themselves to contribute directly to NORSE/FIRES research.
The authors would like to acknowledge the Kohn Family, the generous support from the Robert N. Kohn Research Memorial Fund and all of the families and survivors of NORSE/FIRES who have been paramount in the development of this registry.
Editor’s Note
The table below provides a listing of registries derived from a recent Rare Epilepsy Landscape analysis. 3 More details can be found in the original citation.
Abbreviation: NORSE, new-onset refractory status epilepticus.
Footnotes
Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The NORSE Family Registry is generously supported by the Robert N. Kohn Memorial Research Fund.
ORCID iD: Karnig Kazazian 
https://orcid.org/0000-0001-6157-601X
References
- 1.Hirsch LJ, Gaspard N, van Baalen A. et al. Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions. Epilepsia. 2018;59(4):739–744. [DOI] [PubMed] [Google Scholar]
- 2.Gofton TE, Gaspard N, Hocker SE, Loddenkemper T, Hirsch LJ. New onset refractory status epilepticus research. What is on the horizon? Neurology. 2019;92(17):802–810. [DOI] [PubMed] [Google Scholar]
- 3.Miller IP. Raring for change: confluence of scientific discovery and advocate alignment warrants vital new investments in the Epilepsies. Epilepsy Behav. 2020;111:107276. doi:10.1016/j.yebeh.2020.107276 [DOI] [PMC free article] [PubMed] [Google Scholar]